Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome
Congenital Myasthenic SyndromeLambert-Eaton Myasthenic SyndromeNystagmus, Acquired
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, Los Angeles

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jayashri Srinivasan, MD,MCRP,PhD

Lahey Clinic

Related
1 trials

Shared therapeutic areas:

Myasthenic Syndromes, CongenitalLambert-Eaton Myasthenic Syndrome
Similarity Score20%

Kerry H Levin, M.D.

The Cleveland Clinic

Related
1 trials

Shared therapeutic areas:

Lambert-Eaton Myasthenic Syndrome
Similarity Score10%

Simon Edvardson

Hadassah Medical Organization

Related
1 trials

Shared therapeutic areas:

Myasthenic Syndromes, Congenital
Similarity Score10%

Gilbert Youssef, MD

Dana-Farber Cancer Institute

Related
2 trials

Shared therapeutic areas:

Lambert-Eaton Myasthenic Syndrome
Similarity Score10%

David Richman, MD

University of California, Davis

Related
2 trials

Shared therapeutic areas:

Lambert-Eaton Myasthenic Syndrome
Similarity Score10%

Ricardo Maselli, MD

University of California, Davis

Related
1 trials

Shared therapeutic areas:

Myasthenic Syndromes, Congenital

Worked with same sponsors:

Catalyst Pharmaceuticals, Inc.
Similarity Score10%

Leona Holmberg

Fred Hutch/University of Washington Cancer Consortium

Related
4 trials

Shared therapeutic areas:

Lambert-Eaton Myasthenic Syndrome
Similarity Score10%

Steven P Ringel, MD

University of Colorado, Denver

Related
1 trials

Shared therapeutic areas:

Lambert-Eaton Myasthenic Syndrome
Similarity Score10%

Pierre La Rochelle, MD, MSc

Universite Laval

Related
1 trials

Shared therapeutic areas:

Nystagmus, Acquired
Similarity Score10%

Charles W Gorodetzky, MD, PhD

Chief Medical Officer

Related
1 trials

Shared therapeutic areas:

Lambert-Eaton Myasthenic Syndrome

Worked with same sponsors:

Catalyst Pharmaceuticals, Inc.
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02189720PrincipalInvestigator

Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome

Congenital Myasthenic SyndromeLambert-Eaton Myasthenic SyndromeNystagmus, Acquired
Unknown
NCT02970162Phase 3PrincipalInvestigator

Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)

Lambert-Eaton Myasthenic Syndrome
Completed

All 2 trials loaded